Skip to content
Third Generation EGFR TKIs for Acquired Resistance episode artwork

Feb 17, 2016 3 min

Third Generation EGFR TKIs for Acquired Resistance

from GRACEcast Hosted by cancerGRACE Meetings

Dr. Nathan Pennell, Cleveland Clinic, discusses the concept of acquired resistance and new agents designed to address it, including Rociletinib and Merelitinib.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Third Generation EGFR TKIs for Acquired Resistance

0:00 3:07

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of GRACEcast?

This episode is 3 minutes long.

When was this GRACEcast episode published?

This episode was published on February 17, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.